BRIGHT - A phase II, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of multiple doses of LT3001 drug product in subjects with Acute Ischemic Stroke (AIS)

• Protocol code: LT3001-205
• EudraCT code: _
• Research group: Stroke Research
• Service: Neurology
• Principal investigator:  Molina Cateriano, Carlos
• Pathology: Malalties del sistema nerviós
• Phase: Fase II